Financial Daily from THE HINDU group of publications
Saturday, Feb 18, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Industry & Economy - Health


`Govt could delist harmful drugs'

Our Bureau

New Delhi , Feb. 17

THE Union Health Minister, Dr A. Ramadoss, on Friday said that the Government could delist internationally banned drugs such as Nimulid, if the expert committee found that the usage of such medicines is detrimental to people's health.

Replying to a question in the Rajya Sabha on the availability of certain drugs such as Nimulid, Novalgin, Ciza Syspride, Droperol, Furozone, Lomofen, Nise, Furacin, Agarol, D'cold, Vicks Action 500, Sioril, Piperazine and Enteroquinol, that have been discarded globally said, "We have formed a committee of experts which was studying the effects of the drug and if it was found that its use was to the detriment of people's health, the Government will delist it."

A furore was created after Dr Ramadoss quoting experts said that Indians could metabolise certain drugs easily, while the white-skinned people could not. This was strongly disputed by the CPI(M) Member, Ms Brinda Karat, who accused the Minister of coming up with a new "racial theory of drugs" and allowing the country to become a dumping ground for drugs manufactured by multinationals.

Earlier, Dr Ramadoss said that there was no system of global banning or discarding of drugs. Certain formulations or drugs could be withdrawn or banned in one or a few countries, but may continue to be marketed in other countries.

He added that there is an adequate mechanism in the country to review the status of drug formulations as and when any serious adverse event is reported.

A committee of experts assesses such drugs based on available technical information, benefit-risk ratio and local needs.

The Drugs Technical Advisory Board (DTAB), a statutory body under the Drugs and Cosmetics Act, 1940 then examines the issue.

Dr Ramadoss said that so far 76 categories of drugs, considered harmful in the context of present knowledge, had been banned in the country.

More Stories on : Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
The heat is on


Wind mobile charger
Teleradiology to read Singapore NHG scans
Kerala has an image problem with investors: Study
CSO puts software sector's contribution to GDP at 2.7 pc
West Bengal offers sops for investments
Jharkhand Plan size fixed at Rs 6,500 cr
Sri Lanka urges India to address issues affecting bilateral trade
`Govt could delist harmful drugs'
We are committed to pipeline project, say India, Pakistan
Industrial township: WBIIDC looking for joint venture partner
Rangarajan panel for reduction in Customs duties on petrol, diesel — Report submitted to Petroleum Minister
Polymer industry seeks lower excise duty on plastic goods — 'High tax incidence hurting growth'
Power regulators to develop info management system — Aim is to usher in greater regulatory certainty
AP to add 4,000 MW of power by 2008
Vedanta Resources to set up multi-disciplinary varsity
BITS to set up third campus in near Hyderabad
Hyderabad to host medical tech fair
Govt to list profitable CPSEs on domestic stock exchanges
NDA, Left oppose FDI in retail, urge traders to protest
`Armed' with IIM course, retirees march towards new careers
`Domestic manufacturing potential yet to be fully tapped'
ISB to host DFJ-TiE business plan contest
Wooden beauty
Loud and clear
Exporters can remit licence fee thru demand drafts
US export council calls for relaxation of visa rules
Handicraft exports poised for quantum jump: Kamal Nath
Call to widen exporters' base in AP
Singapore Tourism eyes markets in secondary cities
SEBI debars Warner Multimedia, 12 entities
IPO scam: Govt firm on punishing guilty



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line